E-LIB Suche - Ergebnisse für: Ushijima, Sunao

1

A phase II study of S-1 and cisplatin with concurrent thora..:

Tanaka, Hisashi ; Tanzawa, Shigeru ; Misumi, Toshihiro...
Therapeutic Advances in Medical Oncology. 14 (2022) - p. 175883592211427 , 2022

Link: https://doi.org/10.1177/..

2

Prospective analysis of factors precluding the initiation o..:

Tanzawa, Shigeru ; Makiguchi, Tomonori ; Tasaka, Sadatomo...
Therapeutic Advances in Medical Oncology. 14 (2022) - p. 175883592211166 , 2022

Link: https://doi.org/10.1177/..

3

The role of comprehensive analysis with circulating tumor D..:

Sueoka‐Aragane, Naoko ; Nakashima, Chiho ; Yoshida, Hironori...
Cancer Medicine. 10 (2021) 12 - p. 3873-3885 , 2021

Link: https://doi.org/10.1002/..

4

A phase II study of S-1 and cisplatin with concurrent thora..:

Tanzawa, Shigeru ; Ushijima, Sunao ; Shibata, Kazuhiko...
Therapeutic Advances in Medical Oncology. 13 (2021) - p. 175883592199858 , 2021

Link: https://doi.org/10.1177/..

5

Heterogeneous Tumor-Immune Microenvironments between Primar..:

Tashiro, Takahiro ; Imamura, Kosuke ; Tomita, Yusuke...
International Journal of Molecular Sciences. 21 (2020) 24 - p. 9705 , 2020

Link: https://doi.org/10.3390/..

6

Population Pharmacokinetics and Adverse Events of Erlotinib..:

Endo-Tsukude, Chihiro ; Sasaki, Ji-ichiro ; Saeki, Sho...
Biological & Pharmaceutical Bulletin; Biological and Pharmaceutical Bulletin. 41 (2018) 1 - p. 47-56 , 2018

Link: https://doi.org/10.1248/..

7

P-677 Intrapleural hypotonic cisplatin treatment (HPT) for ..:

Ebi, Noriyuki ; Seto, Takashi ; Yamamoto, Hidehiko...
Lung Cancer. 41 (2003) - p. S263 , 2003

Link: https://doi.org/10.1016/..

8

A phase II study of S-1 and cisplatin with concurrent thora..:

Tanaka, Hisashi ; Tanzawa, Shigeru ; Misumi, Toshihiro...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772940/. , 2022

Link: http://www.ncbi.nlm.nih...

9

Prospective analysis of factors precluding the initiation o..:

Tanzawa, Shigeru ; Makiguchi, Tomonori ; Tasaka, Sadatomo...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340896/. , 2022

Link: http://www.ncbi.nlm.nih...

10

A phase II study of S-1 and cisplatin with concurrent thora..:

Tanzawa, Shigeru ; Ushijima, Sunao ; Shibata, Kazuhiko...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917867/. , 2021

Link: http://www.ncbi.nlm.nih...

11

Heterogeneous Tumor-Immune Microenvironments between Primar..:

Tashiro, Takahiro ; Imamura, Kosuke ; Tomita, Yusuke...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767140/. , 2020

Link: http://www.ncbi.nlm.nih...

12

Prospective analysis of factors precluding the initiation o..:

Shigeru Tanzawa ; Tomonori Makiguchi ; Sadatomo Tasaka...
https://doi.org/10.1177/17588359221116603. , 2022

Link: https://doi.org/10.1177/..

13

A phase II study of S-1 and cisplatin with concurrent thora..:

Hisashi Tanaka ; Shigeru Tanzawa ; Toshihiro Misumi...
https://doi.org/10.1177/17588359221142786. , 2022

Link: https://doi.org/10.1177/..

14

A phase II study of S-1 and cisplatin with concurrent thora..:

Shigeru Tanzawa ; Sunao Ushijima ; Kazuhiko Shibata...
https://doi.org/10.1177/1758835921998588. , 2021

Link: https://doi.org/10.1177/..

15

The role of comprehensive analysis with circulating tumor D..:

Naoko Sueoka‐Aragane ; Chiho Nakashima ; Hironori Yoshida...
https://doi.org/10.1002/cam4.3929. , 2021

Link: https://doi.org/10.1002/..